Sale!

MYH3 Gene Arthrogryposis Distal Type 2B Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MYH3 Gene Arthrogryposis Distal Type 2B Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the MYH3 gene, which are linked to the development of Arthrogryposis Distal Type 2B. This condition is a rare genetic disorder characterized by severe joint contractures and muscle weakness present at birth, primarily affecting the hands and feet. The test plays a crucial role in the early diagnosis and management of the disorder, enabling healthcare professionals to tailor treatment plans and provide genetic counseling to affected families. Priced at 4400 AED, this test is a valuable resource for individuals with a family history of the condition or presenting symptoms suggestive of Arthrogryposis Distal Type 2B, offering insights into the genetic basis of their condition and guiding clinical decisions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MYH3 Gene Arthrogryposis distal type 2B Genetic Test

Cost: AED 4400.0

Test Components:

  • Price: AED 4400.0
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Osteology Dermatology Immunology Disorders
  • Doctor: Dermatologist
  • Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for MYH3 Gene Arthrogryposis, distal, type 2B NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MYH3 Gene Arthrogryposis, distal, type 2B NGS Genetic DNA Test gene MYH3.

Test Details:

Arthrogryposis, distal, type 2B (DA2B) is a genetic disorder characterized by multiple joint contractures, primarily affecting the hands and feet. It is caused by mutations in the MYH3 gene. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, providing a comprehensive analysis of an individual’s genetic makeup.

In the case of DA2B, NGS genetic testing can identify mutations in the MYH3 gene that are responsible for causing the disorder. The MYH3 gene provides instructions for making a protein called embryonic myosin heavy chain 3, which is involved in muscle contraction and development during fetal development. Mutations in this gene can disrupt the normal function of the protein, leading to the characteristic joint contractures seen in DA2B.

NGS genetic testing for MYH3 gene mutations can help confirm a diagnosis of DA2B in individuals with clinical symptoms suggestive of the disorder. It can also be used for carrier testing in individuals with a family history of DA2B, as well as for prenatal testing in families with a known MYH3 gene mutation.

Genetic testing can provide important information for individuals and families affected by DA2B, including accurate diagnosis, prognosis, and the potential for genetic counseling and family planning. It is important to consult with a healthcare professional or a genetic counselor to discuss the benefits, limitations, and implications of genetic testing for DA2B.

Test Name MYH3 Gene Arthrogryposis distal type 2B Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MYH3 Gene Arthrogryposis, distal, type 2B NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MYH3 Gene Arthrogryposis, distal, type 2B NGS Genetic DNA Test gene MYH3
Test Details

Arthrogryposis, distal, type 2B (DA2B) is a genetic disorder characterized by multiple joint contractures, primarily affecting the hands and feet. It is caused by mutations in the MYH3 gene.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, providing a comprehensive analysis of an individual’s genetic makeup. In the case of DA2B, NGS genetic testing can identify mutations in the MYH3 gene that are responsible for causing the disorder.

The MYH3 gene provides instructions for making a protein called embryonic myosin heavy chain 3, which is involved in muscle contraction and development during fetal development. Mutations in this gene can disrupt the normal function of the protein, leading to the characteristic joint contractures seen in DA2B.

NGS genetic testing for MYH3 gene mutations can help confirm a diagnosis of DA2B in individuals with clinical symptoms suggestive of the disorder. It can also be used for carrier testing in individuals with a family history of DA2B, as well as for prenatal testing in families with a known MYH3 gene mutation.

Genetic testing can provide important information for individuals and families affected by DA2B, including accurate diagnosis, prognosis, and the potential for genetic counseling and family planning. It is important to consult with a healthcare professional or a genetic counselor to discuss the benefits, limitations, and implications of genetic testing for DA2B.